×
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF
$ 40.00
Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression PDF quantity
$ 40.00
×
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF
$ 40.00
An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder PDF quantity
$ 40.00
×
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study PDF
$ 40.00
Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results From the Baltimore Epidemiologic Catchment Area Study PDF quantity
$ 40.00
×
Role of Mirtazapine in the Pharmacotherapy of Depression PDF
$ 40.00
Role of Mirtazapine in the Pharmacotherapy of Depression PDF quantity
$ 40.00
×
Open-Label Trial of Escitalopram in the Treatment of Posttraumatic Stress Disorder PDF
$ 40.00
Open-Label Trial of Escitalopram in the Treatment of Posttraumatic Stress Disorder PDF quantity
$ 40.00
×
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial PDF
$ 40.00
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder: A 52-Week, Open-Label, Multicenter Study PDF
$ 40.00
Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder: A 52-Week, Open-Label, Multicenter Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart